Targeting the Relaxin Pathway for Liver Disease Treatment
Hepatic fibrosis is a progressive disease with few treatment options outside of transplantation. Relaxin is a member of the insulin/relaxin superfamily of peptide hormones. Originally known for its roles in pregnancy, relaxin promotes reproductive tissue remodelling and regulates vascular changes, i...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2018-05-01
|
| Series: | European Medical Journal Hepatology |
| Subjects: | |
| Online Access: | https://www.emjreviews.com/hepatology/article/targeting-the-relaxin-pathway-for-liver-disease-treatment/ |